Home Spirometry Bluetooth Device Global Market Report 2025

The home spirometry Bluetooth device market size has grown rapidly in recent years. It will grow from $1.16 billion in 2024 to $1.28 billion in 2025 at a compound annual growth rate (CAGR) of 10.6%. The growth during the historic period can be attributed to the rising prevalence of chronic respiratory diseases, increasing awareness of lung health monitoring, greater adoption of home-based patient care, a surge in hospital readmissions related to respiratory conditions, the expansion of remote patient management programs, and higher healthcare spending on respiratory diagnostics.

The home spirometry Bluetooth device market size is expected to see rapid growth in the next few years. It will grow to $1.89 billion in 2029 at a compound annual growth rate (CAGR) of 10.3%. The growth during the forecast period can be attributed to the rising prevalence of asthma among aging populations, increased emphasis on early disease detection and prevention, a growing shift toward value-based healthcare models, greater patient preference for home-based monitoring, expansion of reimbursement policies for home healthcare, and the increasing burden of respiratory complications related to pollution. Key trends in the forecast period include advancements in Bluetooth connectivity, innovations in portable respiratory devices, development of artificial intelligence-driven diagnostic tools, research and development in remote monitoring platforms, and progress in cloud-based health data analytics.

The rising prevalence of chronic respiratory diseases is expected to drive growth in the home spirometry Bluetooth device market amid increasing respiratory health challenges. Chronic respiratory diseases are long-term conditions affecting the airways and other lung structures, leading to reduced lung function and overall respiratory health. Their prevalence is rising primarily due to the aging population, as older individuals face a higher risk of respiratory conditions from natural declines in lung function and prolonged exposure to environmental irritants. Home spirometry Bluetooth devices enable real-time remote monitoring of lung function in patients with chronic respiratory diseases, facilitating early detection of worsening conditions, timely medical interventions, and improved long-term management. For example, in May 2025, the Centers for Disease Control and Prevention reported that chronic obstructive pulmonary disease (COPD) was the fifth leading cause of death in the United States in 2023, causing 141,733 deaths. In the same year, the age-adjusted prevalence of diagnosed COPD among adults aged 18 years and older was 3.8 percent. This rising prevalence is a key factor driving the expansion of the home spirometry Bluetooth device market.

Leading companies in the home spirometry Bluetooth device market are focusing on developing innovative solutions to advance home-based lung health monitoring. The Air Next Spirometer supports remote patient management and early detection of respiratory conditions such as asthma and COPD. This Bluetooth-enabled, smartphone-connected home spirometry device accurately measures lung function and transmits real-time respiratory data for remote monitoring and management. In January 2024, NuvoAir Medical, a US-based company providing personalized heart and lung care, announced that its Air Next Spirometer received formal 510(k) clearance from the U.S. Food and Drug Administration for in-home use as a full spirometer. This approval allows patients to perform comprehensive lung function tests, including forced expiratory volume (FEV1) and forced vital capacity (FVC), at home, with data shared with healthcare providers for continuous management. The clearance also supports clinical trials, research, and routine lung health monitoring outside traditional healthcare facilities, promoting more accessible and continuous respiratory care.

In January 2023, CAIRE Inc., a US-based manufacturer of oxygen therapy and respiratory care solutions, acquired MGC Diagnostics Holdings, Inc. for an undisclosed amount. The acquisition aims to expand CAIRE’s portfolio into cardiorespiratory diagnostic technologies and enhance patient care across awareness, diagnosis, therapy, and monitoring. It also leverages CAIRE’s global network to improve access and strengthen its presence in the pulmonary and cardiorespiratory clinical market. MGC Diagnostics Holdings, Inc. manufactures Bluetooth-enabled home spirometers such as the GoSpiro.

Major players in the home spirometry bluetooth device market are Contec Medical Systems Co. Ltd., Vitalograph Ltd., Medcaptain Medical Technology Co. Ltd., Medical International Research S.p.A., CareSimple Inc., Geratherm Medical AG, SDI Diagnostics Inc., NDD Medical Technologies, Futuremed America Inc., Sibelmed S.L., Uscom Ltd., e-LinkCare Meditech Co. Ltd., Monitored Therapeutics Inc. (MTI), Aluna Health Inc., Jones Medical Instrument Company, CMI Health, Healthup SA, Motustech Inc., Medikro Oy, Icen Technology Company Limited.

North America was the largest region in the home spirometry bluetooth device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in home spirometry Bluetooth device report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The home spirometry bluetooth device market research report is one of a series of new reports that provides home spirometry bluetooth device market statistics, including home spirometry bluetooth device industry global market size, regional shares, competitors with a home spirometry bluetooth device market share, detailed home spirometry bluetooth device market segments, market trends and opportunities, and any further data you may need to thrive in the home spirometry bluetooth device industry. The home spirometry bluetooth device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

A home spirometry Bluetooth device is a medical tool that assesses lung function and airflow capacity. It records respiratory data in real time and sends it wirelessly via Bluetooth to connected devices. The device allows continuous tracking of breathing patterns, supporting proactive management of respiratory health. Its primary benefit is delivering accurate, immediate, and easily accessible pulmonary measurements at home.

The primary categories of home spirometry Bluetooth devices include handheld devices and tabletop devices. Handheld devices are portable spirometers designed for at-home lung function monitoring with Bluetooth connectivity. These devices offer various connectivity options, including Bluetooth, wireless fidelity (Wi-Fi), and others, and are available through multiple distribution channels such as online and offline. They are used for a range of conditions, including chronic obstructive pulmonary disease (COPD), asthma, cystic fibrosis, and more, and the end-users include hospitals and clinics, home care settings, ambulatory surgical centers, and other healthcare facilities.

The countries covered in the home spirometry Bluetooth device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The home spirometry Bluetooth device market consists of sales of spirometers with Bluetooth, peak expiratory flow meters (PEF) with Bluetooth, portable spirometers, and lung function monitoring devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.